BONESUPPORT entered into an agreement with Collagen Matrix on U.S. sales of bone graft substitute products through its own U.S. distribution network, beginning in 4Q18.
In August 2014, we published a list of companies that we thought were at the forefront of fracture repair. Were we right-that they were worthy of watching? How have they fared since then? We searched funding, regulatory clearance and product launch announcements over the past four years to demonstrate thier activity. Let's recap!
Ortho Regenerative Technologies received a Notice of Allowance from the EU Patent Office, which will protect the formulation of Ortho-R biopolymer for the biologic repair of tissue.